Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 185

1.

Local delivery of cannabinoid-loaded microparticles inhibits tumor growth in a murine xenograft model of glioblastoma multiforme.

Hernán Pérez de la Ossa D, Lorente M, Gil-Alegre ME, Torres S, García-Taboada E, Aberturas Mdel R, Molpeceres J, Velasco G, Torres-Suárez AI.

PLoS One. 2013;8(1):e54795. doi: 10.1371/journal.pone.0054795. Epub 2013 Jan 22.

2.

A combined preclinical therapy of cannabinoids and temozolomide against glioma.

Torres S, Lorente M, Rodríguez-Fornés F, Hernández-Tiedra S, Salazar M, García-Taboada E, Barcia J, Guzmán M, Velasco G.

Mol Cancer Ther. 2011 Jan;10(1):90-103. doi: 10.1158/1535-7163.MCT-10-0688.

3.
4.

Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: development, characterization and in vitro evaluation of their antitumoral efficacy.

Hernán Pérez de la Ossa D, Ligresti A, Gil-Alegre ME, Aberturas MR, Molpeceres J, Di Marzo V, Torres Suárez AI.

J Control Release. 2012 Aug 10;161(3):927-32. doi: 10.1016/j.jconrel.2012.05.003. Epub 2012 May 10.

PMID:
22580111
5.

Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP+ affected murine mesencephalic cultures.

Moldzio R, Pacher T, Krewenka C, Kranner B, Novak J, Duvigneau JC, Rausch WD.

Phytomedicine. 2012 Jun 15;19(8-9):819-24. doi: 10.1016/j.phymed.2012.04.002. Epub 2012 May 7.

PMID:
22571976
6.

A tale of two cannabinoids: the therapeutic rationale for combining tetrahydrocannabinol and cannabidiol.

Russo E, Guy GW.

Med Hypotheses. 2006;66(2):234-46. Epub 2005 Oct 4.

PMID:
16209908
7.

Targeting Glioma Initiating Cells with A combined therapy of cannabinoids and temozolomide.

López-Valero I, Saiz-Ladera C, Torres S, Hernández-Tiedra S, García-Taboada E, Rodríguez-Fornés F, Barba M, Dávila D, Salvador-Tormo N, Guzmán M, Sepúlveda JM, Sánchez-Gómez P, Lorente M, Velasco G.

Biochem Pharmacol. 2018 Nov;157:266-274. doi: 10.1016/j.bcp.2018.09.007. Epub 2018 Sep 7.

8.

Cannabinoids Delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta/STAT proinflammatory pathways in BV-2 microglial cells.

Kozela E, Pietr M, Juknat A, Rimmerman N, Levy R, Vogel Z.

J Biol Chem. 2010 Jan 15;285(3):1616-26. doi: 10.1074/jbc.M109.069294. Epub 2009 Nov 12.

9.

A pilot clinical study of Delta9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme.

Guzmán M, Duarte MJ, Blázquez C, Ravina J, Rosa MC, Galve-Roperh I, Sánchez C, Velasco G, González-Feria L.

Br J Cancer. 2006 Jul 17;95(2):197-203. Epub 2006 Jun 27.

11.
12.

Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.

Roser P, Juckel G, Rentzsch J, Nadulski T, Gallinat J, Stadelmann AM.

Eur Neuropsychopharmacol. 2008 Aug;18(8):569-77. doi: 10.1016/j.euroneuro.2008.04.008. Epub 2008 Jun 10.

PMID:
18544469
13.

Differential effects of cannabis extracts and pure plant cannabinoids on hippocampal neurones and glia.

Ryan D, Drysdale AJ, Pertwee RG, Platt B.

Neurosci Lett. 2006 Nov 20;408(3):236-41. Epub 2006 Sep 25.

PMID:
16997463
14.

Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study.

Tomida I, Azuara-Blanco A, House H, Flint M, Pertwee RG, Robson PJ.

J Glaucoma. 2006 Oct;15(5):349-53.

PMID:
16988594
15.

Cannabinoid receptor 1 binding activity and quantitative analysis of Cannabis sativa L. smoke and vapor.

Fischedick J, Van Der Kooy F, Verpoorte R.

Chem Pharm Bull (Tokyo). 2010 Feb;58(2):201-7.

16.

Inhibition of recombinant human T-type calcium channels by Delta9-tetrahydrocannabinol and cannabidiol.

Ross HR, Napier I, Connor M.

J Biol Chem. 2008 Jun 6;283(23):16124-34. doi: 10.1074/jbc.M707104200. Epub 2008 Apr 7.

17.

Simultaneous and sensitive analysis of THC, 11-OH-THC, THC-COOH, CBD, and CBN by GC-MS in plasma after oral application of small doses of THC and cannabis extract.

Nadulski T, Sporkert F, Schnelle M, Stadelmann AM, Roser P, Schefter T, Pragst F.

J Anal Toxicol. 2005 Nov-Dec;29(8):782-9.

PMID:
16356335
18.

Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Delta(9)-tetrahydrocannabinol.

Vann RE, Gamage TF, Warner JA, Marshall EM, Taylor NL, Martin BR, Wiley JL.

Drug Alcohol Depend. 2008 Apr 1;94(1-3):191-8. doi: 10.1016/j.drugalcdep.2007.11.017.

19.

Cannabinoid-induced alterations in brain disposition of drugs of abuse.

Reid MJ, Bornheim LM.

Biochem Pharmacol. 2001 Jun 1;61(11):1357-67.

PMID:
11331071
20.

Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.

Hernán Pérez de la Ossa D, Gil-Alegre ME, Ligresti A, Aberturas Mdel R, Molpeceres J, Torres AI, Di Marzo V.

J Drug Target. 2013 Sep;21(8):710-8. doi: 10.3109/1061186X.2013.809089. Epub 2013 Jun 18.

PMID:
23773072

Supplemental Content

Support Center